UK markets open in 4 hours 31 minutes
NIKKEI 225
38,735.29 -211.64 (-0.54%) HANG SENG
19,353.22 +132.60 (+0.69%) CRUDE OIL
79.06 -0.20 (-0.25%) GOLD FUTURES
2,428.50 +2.60 (+0.11%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
55,262.86 -564.41 (-1.01%)
4D Molecular Therapeutics, Inc. (FDMT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 26.00 |
| Open | 25.06 |
| Bid | 25.13 x 200 |
| Ask | 25.23 x 200 |
| Day's range | 24.73 - 25.95 |
| 52-week range | 9.44 - 36.25 |
| Volume | |
| Avg. volume | 617,269 |
| Market cap | 1.344B |
| Beta (5Y monthly) | 2.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.28 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 52.30 |
Simply Wall St.We're Interested To See How 4D Molecular Therapeutics (NASDAQ:FDMT) Uses Its Cash Hoard To Grow
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Simply Wall St.4D Molecular Therapeutics First Quarter 2024 Earnings: US$0.66 loss per share (vs US$0.88 loss in 1Q 2023)
4D Molecular Therapeutics ( NASDAQ:FDMT ) First Quarter 2024 Results Key Financial Results Revenue: US$28.0k (down 91...
- GuruFocus.com
4D Molecular Therapeutics Inc (FDMT) Q1 2024 Earnings: Misses Analyst Net Income Projections
Comprehensive Analysis of First Quarter Financials and Strategic Developments
© 2024 Yahoo. All rights reserved.